The EOLPC Philosophy
EOLPC is deeply committed to helping anyone overcome their fear of dying. At EOLPC, Psychedelic Care is a holistic approach to mental, emotional and spiritual wellbeing for those with life-threatening or terminal illnesses. We see our role as giving you the information to make an informed decision as to whether psychedelic care is right for you then connecting you with support trained in both psychedelic and end-of-life care.
EOLPC’s goal is to help you make an informed decision. There are many different ways to approach the safe use of psychedelics and our philosophy is to provide the information you need. We do not dictate your decision as it is a very personal one but our emphasis will always be on SAFE use. We welcome all participants who want to learn about psychedelic care, including family members and the community at-large
Special Pricing Ends December 31st, 2023
Sign Up For Course Announcements
Psychedelic Core Course Program to Address End of Life Care
There are six online modules, taught live in an interactive format, over 6 weeks and covers introductory sessions on psilocybin, ketamine, screening and assessment, preparation and integration, and ethical and legal considerations, all with a lens to the end-of-life issues your clients or patients face.
EOLPC focuses on Psilocybin, the most widely researched one in this field and Ketamine, the most widely available one.
Psilocybin is the psychoactive ingredient in “magic mushrooms”. Most people report experiencing mystical consciousness, an indescribable knowing that we all exist as one.
Psilocybin has been widely researched: for almost two decades, universities such as Johns Hopkins, NYU and UCLA have consistently shown that the use of psilocybin-assisted therapy reduces anxiety and depression in participants with advanced-stage cancer. Not only that, participants also confronted their fear of dying, found meaning in their lives and came to feel at peace with their death and dying.
Psilocybin is just now becoming available across the US. Oregon is the first state to institute Licensed Service Centers, set to open in the Fall of 2023. And there are many jurisdictions around the country that allow for “decriminalized” use, as well as churches where members can participate in spiritual and non-denominational ceremonies.
How psilocybin helped cancer patient Kerry Pappas.
Listen to this short video clip as Anderson Cooper interviews Kerry Pappas about her experience in the Johns Hopkins clinical trial using psilocybin-assisted therapy to reduce her anxiety and come to terms with her cancer diagnosis. Courtesy: CBS 60 Minutes.
Ketamine was first approved by the FDA in 1970 as an analgesic and sedative for surgery. Doctors began to realize that ketamine had broader potential when surgical patients began reporting that symptoms related to a number of mental disorders were alleviated. Since the 1990s, it has been safely used off-label to treat chronic pain, anxiety, depression, OCD, PTSD, suicidal ideation and more.
Ketamine has also been studied in palliative care patients and, similar to psilocybin, been shown to decrease anxiety and depression. It is different than psilocybin and it may not cause as mystical a journey but ketamine has a special property all its own that separates you from your body and takes you deep into your subconscious for insights and healing.
Although ketamine treatment often requires multiple medicine sessions as compared to psilocybin, it is widely available across North America and one of the safest medicines around.
One Woman's Ketamine Story.
When Cathy P. was first diagnosed with brain cancer 5 years ago, she suffered debilitating and isolating depression. She found her way to Ketamine Therapy and after the first treatment session, she felt the depression lift and after several more, she found herself experiencing joy. She even started working again, something she hadn’t done in more than 4 years. Both she and her husband learned to enjoy life in the present moment.
After a year, though, painful neuropathy and trigeminal neuralgia surfaced. Cathy was maintaining her mental health with Ketamine “boosters” every 8 weeks but now she turned to it to help with the pain. This dose is much higher but it reduced the pain in her feet and along her jaw line, enough so that she could remain at her job. Ketamine became her best weapon now to manage pain with a regimen of IV sessions and lozenges taken at-home to prolong the relief.